| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |